NASDAQ:ORIC

ORIC Stock Heads Into Weekend as Cancer-Trial Deadline Approaches
····

ORIC Stock Heads Into Weekend as Cancer-Trial Deadline Approaches

Anika Therapeutics shares closed Friday at $14.88, down 0.9% for the day and 0.2% for the week, lagging broader U.S. market gains ahead of the Memorial Day break. The company’s first-quarter revenue rose 13% to $29.6 million, with adjusted EBITDA at $4.3 million. Investors await the June 18 shareholder meeting, with no major company events scheduled before then.
May 23, 2026

Stock Market Today

  • How to Value National Australia Bank (NAB) Shares Using P/E Ratio
    May 29, 2026, 10:18 PM EDT. National Australia Bank Ltd (ASX: NAB) trades around $37, attracting yield-focused investors. A key valuation tool is the price-earnings (P/E) ratio, which compares share price to yearly earnings per share. NAB's P/E ratio stands at 16.5x based on a $37.33 share price and $2.26 earnings per share (EPS). This is below the banking sector average of 18x. Applying the sector average P/E to NAB's EPS suggests a fair value of about $40.72, hinting NAB shares might be undervalued compared to peers. The P/E ratio provides a useful benchmark but should be combined with other analysis methods for robust investment decisions.